Kaili Medical: Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2025

Securities code: 300633 Securities abbreviation: Kaili Medical Announcement number: 2025-058

Shenzhen Kaili Biomedical Technology Co., Ltd.

Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2025

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.

Special tips:

1. No resolution was vetoed at this shareholders’ meeting;

2. This shareholders’ meeting does not involve changes to the resolutions passed by previous shareholders’ meetings.

1. Meeting convening and attendance

(1) Convening situation

1. Convening time:

(1) On-site meeting: December 30, 2025 (Tuesday) 14:30 pm

(2) Online voting: The time for online voting through the trading system of the Shenzhen Stock Exchange is 9:15-9:25 am, 9:30-11:30, and 13:00-15:00 pm on December 30, 2025; the specific time for voting through the Internet system of the Shenzhen Stock Exchange is any time between 9:15-15:00 on December 30, 2025.

2. The venue of the on-site meeting: Conference Room 121 on the first floor of Kaili Medical Building, No. 368 Guangdian North Road, Guangming District, Shenzhen

3. Convening method: combination of on-site voting and online voting

4. Convener: Board of Directors of Shenzhen Kaili Biomedical Technology Co., Ltd.

5. Moderator: Chairman Mr. Chen Zhiqiang

6. The meeting shall be held in compliance with relevant laws, administrative regulations, departmental rules, normative documents and the company's articles of association.

(2) Attendance

1. A total of 127 shareholders and shareholders' authorized representatives attended this shareholders' meeting, representing 238,277,014 shares with voting rights, accounting for 55.3717% of the company's total voting shares.

Among them, a total of 4 shareholders and shareholders' authorized representatives attended the on-site meeting, representing 219,547,753 shares with voting rights, accounting for 51.0194% of the company's total voting shares; 123 shareholders attended the meeting through online voting, representing 18,729,261 shares with voting rights, accounting for 4.3524% of the company's total voting shares. A total of 123 small and medium-sized shareholders (other than shareholders who individually or collectively hold more than 5% of the company's shares and shareholders other than the company's directors, supervisors, and senior managers) and authorized representatives attended this shareholders' meeting, representing 18,729,261 shares with voting rights, accounting for 4.3524% of the company's total shares with voting rights.

(Note: As of the equity registration date of this shareholders’ meeting, the company’s total share capital is 432,712,405 shares, of which 2,390,000 shares have been repurchased in the company’s special securities account for repurchase. The repurchased shares do not have voting rights, so the total number of shares with voting rights for this shareholders’ meeting is 430,322,405 shares.)

2. The company’s directors and supervisors attended the shareholders’ meeting, and the company’s senior managers also attended the shareholders’ meeting.

3. Witnessing lawyers from Beijing Zhonglun (Shenzhen) Law Firm attended the shareholders’ meeting.

2. Proposal review and voting status

This general meeting of shareholders reviewed and voted on the following matters using a combination of on-site voting and online voting:

Proposal 1.00 "Proposal on Abolition of the Supervisory Board, Amending the Articles of Association and Handling Industrial and Commercial Change Registration" Total voting results: 238,051,714 shares were approved, accounting for 99.9054% of the total number of shares with valid voting rights attending this shareholders' meeting; 199,100 shares were opposed, accounting for 0.0836% of the total number of shares with valid voting rights attending this shareholders' meeting; 26,200 abstentions shares (including 1,400 shares that abstained from voting due to non-voting), accounting for 0.0110% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 18,503,961 shares were approved, accounting for 98.7971% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 199,100 shares were opposed, accounting for 1.0630% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 26,200 abstentions shares (of which 1,400 shares abstained by default due to non-voting), accounting for 0.1399% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 2/3 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was approved.

Proposal 2.00 "Proposal on Amending and Establishing Certain Corporate Governance Systems"

This proposal will be voted on item by item. The specific voting details are as follows:

Proposal 2.01 Amend the "Rules of Procedure for Shareholders' Meetings"

Total voting results: 235,878,491 shares were approved, accounting for 98.9934% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,368,823 shares were opposed, accounting for 0.9941% of the total number of shares with valid voting rights present at this shareholders’ meeting; 29,700 shares abstained (of which 1,400 shares abstained by default due to failure to vote) shares), accounting for 0.0125% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,330,738 shares were approved, accounting for 87.1937% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,368,823 shares were opposed, accounting for 12.6477% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 29,700 shares were abstained (of which 1,400 shares were abstained by default due to failure to vote) shares), accounting for 0.1586% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 2/3 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was approved.

Proposal 2.02 Amend the "Rules of Procedures of the Board of Directors"

Total voting results: 235,867,991 shares were approved, accounting for 98.9890% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,380,723 shares were opposed, accounting for 0.9991% of the total number of shares with valid voting rights present at this shareholders’ meeting; 28,300 shares abstained (of which 0 abstentions were defaulted due to failure to vote) shares), accounting for 0.0119% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,320,238 shares were approved, accounting for 87.1377% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,380,723 shares were opposed, accounting for 12.7112% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 28,300 abstained. shares (of which 0 shares abstained by default due to non-voting), accounting for 0.1511% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.

Voting results: This proposal was passed by more than 2/3 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was approved.

Proposal 2.03 Revise the "Working System for Independent Directors"

Total voting results: 235,867,991 shares were approved, accounting for 98.9890% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,380,723 shares were opposed, accounting for 0.9991% of the total number of shares with valid voting rights present at this shareholders’ meeting; 28,300 shares abstained (of which 0 abstentions were defaulted due to failure to vote) shares), accounting for 0.0119% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,320,238 shares were approved, accounting for 87.1377% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,380,723 shares were opposed, accounting for 12.7112% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 28,300 abstained shares (of which 0 shares abstained by default due to non-voting), accounting for 0.1511% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

Proposal 2.04 Amend the "Administrative Measures for Related Party Transactions"

Total voting results: 235,869,391 shares were approved, accounting for 98.9896% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,381,723 shares were opposed, accounting for 0.9996% of the total number of shares with valid voting rights present at this shareholders’ meeting; 25,900 shares abstained (of which 1,000 shares abstained by default due to failure to vote) shares), accounting for 0.0109% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,321,638 shares were approved, accounting for 87.1451% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,381,723 shares were opposed, accounting for 12.7166% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 25,900 shares were abstained (of which 1,000 shares were abstained by default due to failure to vote) shares), accounting for 0.1383% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

Proposal 2.05 Amends the "Overseas Investment Management Measures"

Total voting results: 235,866,091 shares were approved, accounting for 98.9882% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,384,723 shares were opposed, accounting for 1.0008% of the total number of shares with valid voting rights present at this shareholders’ meeting; 26,200 shares abstained (of which 1,000 shares abstained by default due to failure to vote) shares), accounting for 0.0110% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,318,338 shares were approved, accounting for 87.1275% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,384,723 shares were opposed, accounting for 12.7326% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 26,200 shares were abstained (of which 1,000 shares were abstained by default due to failure to vote) shares), accounting for 0.1399% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

Proposal 2.06 Amend the "External Guarantee Management System"

Total voting results: 235,872,391 shares were in favor, accounting for 98.9908% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,378,423 shares were opposed, accounting for 0.9982% of the total number of shares with valid voting rights present at this shareholders’ meeting; 26,200 shares abstained (of which 1,000 shares abstained by default due to failure to vote) shares), accounting for 0.0110% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,324,638 shares were approved, accounting for 87.1611% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,378,423 shares were opposed, accounting for 12.6990% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 26,200 shares were abstained (of which 1,000 shares were abstained by default due to failure to vote) shares), accounting for 0.1399% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

Proposal 2.07 Amend the "Raised Funds Management System"

Total voting results: 235,872,891 shares were approved, accounting for 98.9910% of the total number of shares with valid voting rights present at this shareholders’ meeting; 2,374,423 shares were opposed, accounting for 0.9965% of the total number of shares with valid voting rights present at this shareholders’ meeting; 29,700 shares abstained (of which 1,000 shares abstained by default due to failure to vote) shares), accounting for 0.0125% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 16,325,138 shares were approved, accounting for 87.1638% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 2,374,423 shares were opposed, accounting for 12.6776% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 29,700 shares were abstained (of which 1,000 shares were abstained by default due to failure to vote) shares), accounting for 0.1586% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

Proposal 2.08 Formulate the "Salary Management System"

Total voting results: 238,052,114 shares were approved, accounting for 99.9056% of the total number of shares with valid voting rights present at this shareholders’ meeting; 193,300 shares were opposed, accounting for 0.0811% of the total number of shares with valid voting rights present at this shareholders’ meeting; 31,600 shares abstained (of which 1,000 shares abstained by default due to failure to vote) shares), accounting for 0.0133% of the total number of shares with valid voting rights present at this general meeting of shareholders.

The total voting results of small and medium-sized shareholders: 18,504,361 shares were approved, accounting for 98.7992% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 193,300 shares were opposed, accounting for 1.0321% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 31,600 abstentions shares (of which 1,000 shares abstained by default due to non-voting), accounting for 0.1687% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this general meeting of shareholders.

Voting results: This proposal was passed by more than 1/2 of the valid voting rights held by shareholders attending the shareholders' meeting; the voting result was passed.

3. Legal opinions issued by lawyers

(1) Name of law firm: Beijing Zhonglun (Shenzhen) Law Firm

(2) Lawyers’ names: Wang Jing, Liu Hongyu

(3) Concluding observations: The convening and convening procedures of the company's shareholders' meeting, the qualifications of the persons attending or attending the meeting, the voting procedures and voting results of this shareholders' meeting are all in compliance with the provisions of the "Company Law", "Shareholders' Meeting Rules" and other laws, regulations, normative documents and the "Articles of Association", and are legal and valid.

4. Documents for reference

1. Resolution of the company’s second extraordinary general meeting of shareholders in 2025;

2. "Legal Opinion of Beijing Zhonglun (Shenzhen) Law Firm on the Second Extraordinary General Meeting of Shareholders of Shenzhen Kaili Biomedical Technology Co., Ltd. in 2025" issued by Beijing Zhonglun (Shenzhen) Law Firm.

Announcement is hereby made.

Board of Directors of Shenzhen Kaili Biomedical Technology Co., Ltd.

December 30, 2025